Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes

NCT: NCT07278531 · NOT_YET_RECRUITING

NCT IDNCT07278531
StatusNOT_YET_RECRUITING
Start Date2027-02
Completion2028-08-31
SponsorNYU Langone Health (OTHER)
First posted
Last updated

Brief Summary

The investigators will examine the feasibility, acceptability, and effect of an adaptive dietary intervention over 24 weeks (12-week intervention, 12-week follow-up) among Asian Americans with Type 2 diabetes. Participants (N=120; 60 Chinese Americans and 60 Vietnamese Americans) will be 2:1 randomized to one of two arms: adaptive dietary intervention or standard of care (SC). The intervention will begin with continued glucose monitoring (CGM) use only during weeks 0-4. At week 4, participants who achieve the glycemic control goal (at least an 8% increase in time in range \[TIR\] from baseline) will continue with the CGM alone during weeks 4-12 ("CGM Alone"); otherwise, culturally and linguistically adapted glucose excursion minimization (GEM) will be augmented with CGM ("CGM-GEM").

Frequently Asked Questions

What is Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes?

Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes is a clinical trial registered under NCT07278531. Current status: NOT_YET_RECRUITING.

What is the status of NCT07278531?

The current status of NCT07278531 (Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes) is: NOT_YET_RECRUITING.

When did Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes start?

Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes started on 2027-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.